Matches in Wikidata for { <http://www.wikidata.org/entity/Q73204221> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q73204221 description "article scientifique publié en 1997" @default.
- Q73204221 description "artikull shkencor i botuar më 01 shkurt 1997" @default.
- Q73204221 description "artículu científicu espublizáu en febreru de 1997" @default.
- Q73204221 description "im Februar 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73204221 description "scientific article published on 01 February 1997" @default.
- Q73204221 description "wetenschappelijk artikel" @default.
- Q73204221 description "наукова стаття, опублікована в лютому 1997" @default.
- Q73204221 name "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 name "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 name "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 type Item @default.
- Q73204221 label "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 label "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 label "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 prefLabel "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 prefLabel "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 prefLabel "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 P1104 Q73204221-B392B798-1361-47E4-94F5-5A63FD87B243 @default.
- Q73204221 P1433 Q73204221-4CB4FA06-35C7-4902-A787-08B1E53A42A7 @default.
- Q73204221 P1476 Q73204221-E92E93F8-5E42-40D0-9B72-CE9343D4EF89 @default.
- Q73204221 P2093 Q73204221-B9BC5A8B-E0C3-43D4-9A5A-0112F088AF35 @default.
- Q73204221 P304 Q73204221-F8B6425A-11E2-4376-927E-E2F8CA040409 @default.
- Q73204221 P31 Q73204221-BE399002-5E61-4FAF-A83A-F962A8E04B69 @default.
- Q73204221 P31 Q73204221-a27b0cc7-a3f2-4af0-a55b-523104edf30b @default.
- Q73204221 P433 Q73204221-FD01C639-E01B-4255-BEC4-6DD7E68547EC @default.
- Q73204221 P478 Q73204221-8329F7A8-5C61-4F12-BF36-68C807466115 @default.
- Q73204221 P50 Q73204221-E88EBA0F-B182-4E4D-AA4E-B0B3F0F5D7E1 @default.
- Q73204221 P577 Q73204221-E537D442-7388-48D6-9378-280B5E2C5085 @default.
- Q73204221 P698 Q73204221-2683796F-E981-43BE-B35C-DCAAE4BB0073 @default.
- Q73204221 P698 9094039 @default.
- Q73204221 P1104 "+3" @default.
- Q73204221 P1433 Q6296168 @default.
- Q73204221 P1476 "Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications" @default.
- Q73204221 P2093 "Meade TW" @default.
- Q73204221 P304 "123-125" @default.
- Q73204221 P31 Q13442814 @default.
- Q73204221 P31 Q871232 @default.
- Q73204221 P433 "2" @default.
- Q73204221 P478 "145" @default.
- Q73204221 P50 Q309971 @default.
- Q73204221 P577 "1997-02-01T00:00:00Z" @default.
- Q73204221 P698 "9094039" @default.